CPRX Richard J Daly buys $1.7M worth of shares
Jun 04, 2025, 4:35 AM
0.00%
What does CPRX do
Catalyst Pharmaceuticals, based in Coral Gables, Florida, develops and commercializes novel medicines for rare diseases, including FIRDAPSE for Lambert-Eaton Myasthenic Syndrome and AGAMREE for Duchenne Muscular Dystrophy. The company, which went public in 2006, employs 167 people.
Richard J Daly bought 70,000 shares of CPRX on 30 May at $24.86 per share, worth a total of $1.7M. They now own 199,764 CPRX shares, or a 54% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.